Opinion: Theranos verdict won’t stop next big fraud


Holmes’ case raises the important question of whether the testimony and result will serve as object lessons for investors confronted with cheery promises in the future. Bet your money that the answer is ‘no’. — AFP

Elizabeth Holmes, the founder and CEO of the medical device company Theranos, was convicted Jan 3 on multiple counts of defrauding investors following a four-month trial in federal court in San Jose.

Theranos, which rode a tide of positive publicity in 2013 and 2014 after introducing what it claimed was novel technology for making blood testing simpler, cheaper and more efficient, shut down in 2018 after investigations established that the claims were false. Holmes and her second-in-command, Ramesh “Sunny” Balwani, were indicted on 12 counts of fraud in 2020 one count was later dropped. Balwani’s trial is scheduled for this year.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Tech News

Evolution of smartphone damage: From drips to drops
Are you tracking your health with a device? Here's what could happen with the data
US judge rejects SEC bid to sanction Elon Musk
What's really happening when you agree to a website's terms of service
Samsung ordered to pay $118 million for infringing Netlist patents
Sirius XM found liable in New York lawsuit over subscription cancellations
US Supreme Court tosses case involving securities fraud suit against Facebook
Amazon doubles down on AI startup Anthropic with another $4 billion
Factbox-Who are bankrupt Northvolt's creditors?
UK should use new powers to probe Apple-Google mobile browser duopoly, report says

Others Also Read